Drug–Radiotherapy Combination Trial Developments—Response

In a recent issue of Clinical Cancer Research , we reviewed and discussed key methodologic basic and clinical research aspects that could inform precision drug–radiotherapy trial optimization ([1][1]). We thank the University of Michigan (Ann Arbor, MI) group for underlining that radiotherapy-